Fundz

Provention Bio Announces Completion Of $35 Million Equity Investment From Sanofi Us

PRIVATEFeb 13, 2023

Amount Raised

$35 Million

Round Type

Venture

Red BankBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharma

Investors

SanofiSanofi Us

Description

Provention Bio, Inc. (Nasdaq: PRVB) (the "Company"), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today announced the closing of the $35 million equity investment from Sanofi US under the previously announced Co-Promotion Agreement and Securities Purchase Agreement (the "Purchase Agreement").

Quick answer

Provention Bio raised $35 Million in a funding round, dated February 13, 2023. Investors: Sanofi and Sanofi Us. Provention Bio is based in Red Bank, New Jersey, United States.

How much did Provention Bio raise?
Provention Bio raised $35 Million in a funding round on February 13, 2023.
Who invested in Provention Bio?
Sanofi and Sanofi Us are named as investors in this round.
What does Provention Bio do?
Provention Bio is a biopharmaceutical company focused on advancing the development of investigational therapies that may intercept and prevent debilitating and life-threatening immune-mediated diseases.
Where is Provention Bio based and how big is it?
Provention Bio is based in Red Bank, New Jersey, United States.

Source: Fundz verified event record.

Who else raised in Therapeutics and Pharmaceutical around the same time

Companies in the same sectors as Provention Bio that raised within 45 days of this round, from Fundz verified event records.

  • Milestone Pharmaceuticals raised $125M on March 28, 2023.
  • Disc raised $63M (Funding Round) on February 14, 2023.
  • CUREMARK LLC raised $1.3M (Seed) on January 30, 2023.
  • HighTide Therapeutics raised $107M (Series C) on January 5, 2023.
  • OnKure Therapeutics raised $57M on March 24, 2023.
  • Entero Therapeutics raised $4M (Seed) on March 15, 2023.

Who to call at Provention Bio, and when

A new round usually means Provention Bio is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Provention Bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Provention Bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Provention Bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Provention Bio

Location

110 OLD DRIFTWAY LANE

Red Bank, New Jersey, United States

About

Provention Bio is a biopharmaceutical company focused on advancing the development of investigational therapies that may intercept and prevent debilitating and life-threatening immune-mediated diseases. At Provention Bio, we approach autoimmune disease differently than traditional pharma, with a clear focus on early interception. Before symptoms present, before irreversible damage is done to the bodies, minds, and lives of patients and families, and before it’s too late —this is where we operate. Our lead investigational product candidate is currently under review by the U.S. Food and Drug Administration (FDA) for the delay or prevention of clinical type 1 diabetes in at-risk individuals. Our pipeline includes additional clinical-stage product candidates for autoimmune diseases, including celiac disease and lupus. We have a vision to change the world by unleashing the full potential of lives otherwise burdened or cut short by autoimmune disease. It may seem daunting, but once we realize the potential of every moment we can protect—in every life we can change—the work we do at Provention Bio becomes more than just a job. It becomes a calling. Provention Bio is an Equal Opportunity Employer. We invite you to learn more at www.ProventionBio.com and connect by following us on LinkedIn and Twitter (@ProventionBio).

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Provention Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Provention Bio's next move

See what Strategic adds

Provention Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.